The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cardiomyocyte Stiffness in Diastolic Heart Failure
Open accessAbstract
BACKGROUND: Heart failure with preserved left ventricular (LV) ejection fraction (EF) is increasingly recognized and usually referred to as diastolic heart failure (DHF). Its pathogenetic mechanism remains unclear, partly because of a lack of myocardial biopsy material. Endomyocardial biopsy samples obtained from DHF patients were therefore analyzed for collagen volume fraction (CVF) and sarcomeric protein composition and compared with control samples. Single cardiomyocytes were isolated from these biopsy samples to assess cellular contractile performance. METHODS AND RESULTS: DHF patients (n=12) had an LVEF of 71+/-11%, an LV end-diastolic pressure (LVEDP) of 28+/-4 mm Hg, and no significant coronary artery stenoses. DHF patients had higher CVFs (7.5+/-4.0%, P<0.05) than did controls (n=8, 3.8+/-2.0%), and no conspicuous changes in sarcomeric protein composition were detected. Cardiomyocytes, mechanically isolated and treated with Triton X-100 to remove all membranes, were stretched to a sarcomere length of 2.2 microm and activated with solutions containing varying [Ca2+]. Compared with cardiomyocytes of controls, cardiomyocytes of DHF patients developed a similar total isometric force at maximal [Ca2+], but their resting tension (F(passive)) in the absence of Ca2+ was almost twice as high (6.6+/-3.0 versus 3.5+/-1.7 kN/m2, P<0.001). F(passive) and CVF combined yielded stronger correlations with LVEDP than did either alone. Administration of protein kinase A (PKA) to DHF cardiomyocytes lowered F(passive) to control values. CONCLUSIONS: DHF patients had stiffer cardiomyocytes, as evident from a higher F(passive) at the same sarcomere length. Together with CVF, F(passive) determined in vivo diastolic LV dysfunction. Correction of this high F(passive) by PKA suggests that reduced phosphorylation of sarcomeric proteins is involved in DHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased Fpassive has been observed in HFpEF patient biopsies, and increased cardiac stiffening is associated with aging.38,39”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Kawaguchi, M., Hay, I., Fetics, B. J., & Kass, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000048123.22359.a0 · Cited by 929
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease
Brilla, C. G., FUNCK, R. C., & Rupp, H. (2000) · Circulation · doi:10.1161/01.cir.102.12.1388 · Cited by 653
How to diagnose diastolic heart failure
Paulus, W. J., Brutsaert, D. L., Gillebert, T. C., Rademakers, F., Stanislas, U., Leite-Moreira, A. F., Om, H., Zh, J., Kaufmann, P. A., Mandinov, L., et al. (1998) · Ghent University Academic Bibliography (Ghent University) · Cited by 649
How to diagnose diastolic heart failure
European Study Group on Diastolic H (1998) · European Heart Journal · doi:10.1053/euhj.1998.1057 · Cited by 616
Research works printed but not linked: 9
Cited by
Sorted by citations
Items 101–200 of 534
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Martino, A. D., Albanese, G., Marfella, R., Sardu, C., et al. (2021) · Biomolecules · doi:10.3390/biom11121834 · Cited by 99
Understanding heart failure with preserved ejection fraction: where are we today?
van Heerebeek, L., & Paulus, W. J. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0810-1 · Cited by 97
Florijn, B. W., Bijkerk, R., van der Veer, E. P., & van Zonneveld, A. J. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx223 · Cited by 95
New Molecular Mechanism in Diastolic Heart Failure
Katz, A. M., & Zile, M. R. (2006) · Circulation · doi:10.1161/circulationaha.106.620765 · Cited by 93
Cardiac metabolism — A promising therapeutic target for heart failure
Noordali, H., Loudon, B. L., Frenneaux, M. P., & Madhani, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.001 · Cited by 94
Pathophysiology of the right ventricle and its pulmonary vascular interaction
Hemnes, A. R., Celermajer, D. S., D’Alto, M., Haddad, F., Hassoun, P. M., Prins, K. W., Naeije, R., & Noordegraaf, A. V. (2024) · European Respiratory Journal · doi:10.1183/13993003.01321-2024 · Cited by 92
The (dys)functional extracellular matrix
Freedman, B. R., Bade, N. D., Riggin, C. N., Zhang, S., Haines, P. G., Ong, K. L., & Janmey, P. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.015 · Cited by 98
Hill, M. A., Jaisser, F., & Sowers, J. R. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa326 · Cited by 91
van der Velden, J., Asselbergs, F. W., Bakkers, J., Bátkai, S., Bertrand, L., Bezzina, C. R., Bot, I., Brundel, B. J. J. M., Carrier, L., Chamuleau, S. A. J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab370 · Cited by 96
Titin: Physiological Function and Role in Cardiomyopathy and Failure
Granzier, H. L. M., Wu, Y., Labeit, S., & LeWinter, M. M. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-5251-7 · Cited by 91
Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium
Piroddi, N., Belus, A., Scellini, B., Tesi, C., Giunti, G., Cerbai, E., Mugelli, A., & Poggesi, C. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0181-3 · Cited by 89
Schwarzl, M., Hamdani, N., Seiler, S., Alogna, A., Manninger, M., Reilly, S. N., Zirngast, B., Kirsch, A. H., Paul Steendijk, A., Verderber, J., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00542.2015 · Cited by 89
Krüger, M., Babicz, K., von Frieling-Salewsky, M., & Linke, W. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.02.012 · Cited by 87
Mouse intact cardiac myocyte mechanics: cross-bridge and titin-based stress in unactivated cells
King, N. M. P., Methawasin, M., Nedrud, J., Harrell, N. B., Chung, C. S., Helmes, M., & Granzier, H. L. M. (2010) · The Journal of General Physiology · doi:10.1085/jgp.201010499 · Cited by 86
Pagel, P. S., Tawil, J. N., Boettcher, B. T., Izquierdo, D. A., Lazicki, T. J., Crystal, G. J., & Freed, J. K. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.016 · Cited by 86
Esposito, G., Cappetta, D., Russo, R., Rivellino, A., Ciuffreda, L. P., Roviezzo, F., Piegari, E., Berrino, L., Rossi, F., Angelis, A. D., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13686 · Cited by 81
Kooij, V., Boontje, N. M., Zaremba, R., Jaquet, K., dos Remedios, C. G., Stienen, G. J. M., & van der Velden, J. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0053-z · Cited by 81
Chopra, A., Lin, V., McCollough, A., Atzet, S. K., Prestwich, G. D., Wechsler, A. S., Murray, M. E., Oake, S. A., Kresh, J. Y., & Janmey, P. A. (2011) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2011.11.023 · Cited by 79
A guide for assessment of myocardial stiffness in health and disease
Lizardi, J. C. V., Baranger, J., Nguyen, M. B., Asnacios, A., Malik, A., Lumens, J., Mertens, L., Friedberg, M. K., Simmons, C. A., Pernot, M., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00007-3 · Cited by 85
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium
van der Velden, J., Narolska, N. A., Lamberts, R. R., Boontje, N. M., Borbély, A., Zaremba, R., Bronzwaer, J. G. F., Papp, Z., Jaquet, K., & Paulus, W. J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.021 · Cited by 78
Lipotoxicity: a driver of heart failure with preserved ejection fraction?
Leggat, J., Bidault, G., & Vidal‐Puig, A. (2021) · Clinical Science · doi:10.1042/cs20210127 · Cited by 74
Franssen, C., & Miqueo, A. G. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0812-z · Cited by 76
Hypertension as a Risk Factor for Heart Failure
Kannan, A., & Janardhanan, R. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0447-7 · Cited by 75
Mechanical and Energetic Consequences of HCM-Causing Mutations
Ferrantini, C., Belus, A., Piroddi, N., Scellini, B., Tesi, C., & Poggesi, C. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9131-8 · Cited by 75
Urban, M. W., Pislaru, C., Nenadic, I., Kinnick, R. R., & Greenleaf, J. F. (2012) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2012.2222656 · Cited by 74
Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies
Zaremba, R., Merkus, D., Hamdani, N., Lamers, J. M. J., Paulus, W. J., dos Remedios, C. G., Duncker, D. J., Stienen, G. J. M., & van der Velden, J. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200600891 · Cited by 74
The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74
Hoskins, A. C., Jacques, A. M., Bardswell, S. C., McKenna, W. J., Tsang, V. T., dos Remedios, C. G., Ehler, E., Adams, K., Jalilzadeh, S., Avkiran, M., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.006 · Cited by 71
Kooij, V., Saes, M., Jaquet, K., Zaremba, R., Foster, D. B., Murphy, A. M., dos Remedios, C., van der Velden, J., & Stienen, G. J. M. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.002 · Cited by 73
Zile, M. R., & Baicu, C. F. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9472-1 · Cited by 71
Myofilament dysfunction in cardiac disease from mice to men
Hamdani, N., de Waard, M., Messer, A. E., Boontje, N. M., Kooij, V., van Dijk, S. J., Versteilen, A. M. G., Lamberts, R. R., Merkus, D., dos Remedios, C. G., et al. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-008-9160-y · Cited by 71
Regan, J. A., Mauro, A. G., Carbone, S., Marchetti, C., Gill, R., Mezzaroma, E., Raleigh, J. V., Salloum, F. N., Tassell, B. W. V., Abbate, A., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00282.2015 · Cited by 71
Miragoli, M., Sanchez‐Alonso, J. L., Bhargava, A., Wright, P., Sikkel, M. B., Schobesberger, S., Diakonov, I. A., Novák, P., Castaldi, A., Cattaneo, P., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.014 · Cited by 70
Primeßnig, U., Schönleitner, P., Höll, A., Pfeiffer, S., Bracic, T., Rau, T., Kapl, M., Stojaković, T., Glasnov, T. N., Leineweber, K., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.524 · Cited by 70
Ribeiro, M. C., Slaats, R. H., Schwach, V., Rivera‐Arbeláez, J. M., Tertoolen, L. G. J., van Meer, B. J., Molenaar, R., Mummery, C. L., Claessens, M. M. A. E., & Passier, R. C. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.03.008 · Cited by 71
Cornuault, L., Rouault, P., Duplàa, C., Couffinhal, T., & Renault, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.906272 · Cited by 72
Pathophysiological insights into HFpEF from studies of human cardiac tissue
Fayyaz, A. U., Eltony, M., Prokop, L. J., Koepp, K. E., Borlaug, B. A., Dasari, S., Bois, M. C., Margulies, K. B., Maleszewski, J. J., Wang, Y., et al. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01067-1 · Cited by 75
Myofilament Degradation and Dysfunction of Human Cardiomyocytes in Fabry Disease
Chimenti, C., Hamdani, N., Boontje, N. M., COBELLI, F. D., Esposito, A., Bronzwaer, J. G. F., Stienen, G. J. M., Russo, M. A., Paulus, W. J., Frustaci, A., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070576 · Cited by 67
Diastolic heart failure: a myth
Brutsaert, D. L., & Keulenaer, G. W. D. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221587.02114.da · Cited by 68
Myocardial Titin and Collagen in Cardiac Diastolic Dysfunction
Hamdani, N., & Paulus, W. J. (2013) · Circulation · doi:10.1161/circulationaha.113.003437 · Cited by 67
Why does troponin I have so many phosphorylation sites? Fact and fancy
Solaro, R. J., & van der Velden, J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.02.014 · Cited by 66
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology
Maurer, M. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.039 · Cited by 66
Cesare, E. D., Battisti, S., Sibio, A. D., Cipriani, P., Giacomelli, R., Liakouli, V., Ruscitti, P., & Masciocchi, C. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.02.014 · Cited by 66
Ohara, T., Niebel, C. L., Stewart, K. C., Charonko, J., Pu, M., Vlachos, P. P., & Little, W. C. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.05.013 · Cited by 65
Narolska, N. A., Eiras-Penas, S., van Loon, R. B., Boontje, N. M., Zaremba, R., berg, S. R. S., Stooker, W., Huybregts, M. A. J. M., Visser, F. C., van der Velden, J., et al. (2005) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-005-9005-x · Cited by 65
The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies
Cai, Z., Wu, C., Xu, Y., Cai, J., Zhao, M., & Zu, L. (2022) · Aging and Disease · doi:10.14336/ad.2022.0523 · Cited by 69
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
Friebel, J., Weithäuser, A., Witkowski, M., Rauch, B. H., Savvatis, K., Dörner, A., Tabaraie, T., Kašner, M., Moos, V., Bösel, D., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz117 · Cited by 68
Lewis, G. A., Schelbert, E. B., Naish, J. H., Bedson, E., Dodd, S. R., Eccleson, H., Clayton, D., Duran-Jimenez, B., McDonagh, T. A., Williams, S. G., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06876-y · Cited by 62
Long-term Inhibition of Rho-kinase Ameliorates Diastolic Heart Failure in Hypertensive Rats
Fukui, S., Fukumoto, Y., Suzuki, J., Saji, K., Nawata, J., Tawara, S., Shinozaki, T., Kagaya, Y., & Shimokawa, H. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31816533b7 · Cited by 60
Adeniran, I., MacIver, D. H., Hancox, J. C., & Zhang, H. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00078 · Cited by 63
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Rech, M., Aizpurua, A. B., van Empel, V. P. M., van Bilsen, M., & Schroen, B. L. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy049 · Cited by 61
Lamberts, R. R., Lingam, S. J., Wang, H.-Y., Bollen, I. A., Hughes, G., Galvin, I. F., Bunton, R. W., Bahn, A., Katare, R., Baldi, J., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-72 · Cited by 60
Kumar, M., Govindan, S., Zhang, M., Khairallah, R. J., Martin, J. W., Sadayappan, S., & de Tombe, P. P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686790 · Cited by 60
Genetic and environmental determinants of diastolic heart function
Thanaj, M., Mielke, J., McGurk, K. A., Bai, W., Savioli, N., de Marvao, A., Meyer, H. V., Zeng, L., Sohler, F., Lumbers, R. T., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00048-2 · Cited by 53
Heart Failure With Normal Left Ventricular Ejection Fraction: What is the Evidence?
Kindermann, M., Reil, J., Pieske, B. M., van Veldhuisen, D. J., & Böhm, M. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.12.003 · Cited by 59
Aslam, M., Hahn, V. S., Jani, V., Hsu, S., Sharma, K., & Kass, D. A. (2020) · Circulation · doi:10.1161/circulationaha.120.052414 · Cited by 60
Hamdani, N., Paulus, W. J., van Heerebeek, L., Borbély, A., Boontje, N. M., Zuidwijk, M. J., Bronzwaer, J. G. F., Simonides, W. S., Niessen, H. W. M., Stienen, G. J. M., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp189 · Cited by 57
Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges
Andersen, M. J., & Borlaug, B. A. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0501-8 · Cited by 59
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload
Falcão‐Pires, I., Palladini, G., Gonçalves, N., van der Velden, J., Moreira‐Gonçalves, D., Miranda‐Silva, D., Salinaro, F., Paulus, W. J., Niessen, H. W. M., Perlini, S., et al. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0184-x · Cited by 58
Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction
Tam, M., Lee, R., CASCINO, T. M., Konerman, M. C., & Hummel, S. L. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0709-2 · Cited by 57
Heart Failure With Preserved Ejection Fraction What is Known and Unknown
Yamamoto, K., Sakata, Y., Ohtani, T., Takeda, Y., & Mano, T. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1073 · Cited by 57
Benech, J. C., Benech, N., Zambrana, A. I., Rauschert, I., Bervejillo, V., Oddone, N., & Damián, J. P. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00192.2013 · Cited by 57
Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients
Starčević, J. N., Janić, M., & Šabović, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051197 · Cited by 59
Rosalia, L., Öztürk, Ç., Shoar, S., Fan, Y., Malone, G., Cheema, F. H., Conway, C., Byrne, R. A., Duffy, G. P., Malone, A. J., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.06.002 · Cited by 56
Mechanisms of Diastolic Dysfunction in Heart Failure With a Preserved Ejection Fraction
LeWinter, M. M., & Meyer, M. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000825 · Cited by 57
Diastolic Dysfunction as a Link Between Hypertension and Heart Failure
Verma, A., & Solomon, S. D. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.013 · Cited by 58
Kozàkovà, M., Morizzo, C., Fraser, A. G., & Palombo, C. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0557-z · Cited by 55
Heart Failure with Preserved Ejection Fraction
Zouein, F. A., Brás, L. E. D. C., da Costa, D. V., Lindsey, M. L., Kurdi, M., & Booz, G. W. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829a4e61 · Cited by 53
Molecular determinants of heart failure with normal left ventricular ejection fraction
Borbély, A., Papp, Z., Edes, I. F., & Paulus, W. J. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70016-7 · Cited by 54
Kov́acs, Á., Alogna, A., Post, H., & Hamdani, N. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0814-x · Cited by 53
Discovery of Titin and Its Role in Heart Function and Disease
Granzier, H. L. M., & Labeit, S. (2025) · Circulation Research · doi:10.1161/circresaha.124.323051 · Cited by 55
Novel therapies in acute and chronic heart failure
Aronson, D., & Krum, H. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.002 · Cited by 51
Wijnker, P. J. M., Foster, D. B., Tsao, A. L., Frazier, A. H., dos Remedios, C. G., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00498.2012 · Cited by 50
Cardiac Magnetic Resonance Elastography
Elgeti, T., Rump, J., Hamhaber, U., Papazoglou, S., Hamm, B., Braun, J., & Sack, I. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181822085 · Cited by 50
Kamimura, D., Ohtani, T., Sakata, Y., Mano, T., Takeda, Y., Tamaki, S., Omori, Y., Tsukamoto, Y., Furutani, K., Komiyama, Y., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr106 · Cited by 50
Diastolic myofilament dysfunction in the failing human heart
van der Velden, J. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0960-3 · Cited by 49
Kolijn, D., Kov́acs, Á., Herwig, M., Lódi, M., Sieme, M., Haj, A. A., Sandner, P., Papp, Z., Reusch, H. P., Haldenwang, P. L., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00345 · Cited by 50
Hall, C., Law, J. P., Reyat, J. S., Cumberland, M. J., Hang, S., Vo, N. T. N., Raniga, K., Weston, C. J., O’Shea, C., Townend, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39369-y · Cited by 54
Hidalgo, C. G., Saripalli, C., & Granzier, H. L. M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.02.010 · Cited by 48
Quantification of myocardial fibrosis by digital image analysis and interactive stereology
Daunoravičius, D., Besusparis, J., Žurauskas, E., Laurinavičienė, A., Bironaitė, D., Pankuweit, S., Plancoulaine, B., Herlin, P., Bogomolovas, J., Grabauskienė, V., et al. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-114 · Cited by 48
Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure
Wood, K. C., Gladwin, M. T., & Straub, A. C. (2019) · Heart · doi:10.1136/heartjnl-2019-314810 · Cited by 48
Female Heart Health: Is GPER the Missing Link?
Groban, L., Tran, Q., Ferrario, C. M., Sun, X., Cheng, C. P., Kitzman, D. W., Wang, H., & Lindsey, S. H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00919 · Cited by 49
Hypertension and heart failure: a dysfunction of systole, diastole or both?
Yip, G. W., Fung, J. W. H., Tan, Y. T., & Sanderson, J. E. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.141 · Cited by 48
Kötter, S., Kazmierowska, M., Andresen, C., Bottermann, K., Grandoch, M., Gorreßen, S., Heinen, A., Moll, J. M., Scheller, J., Gödecke, A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309685 · Cited by 47
The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF
Webb, J., Fovargue, L., Tøndel, K., Porter, B., Sieniewicz, B., Gould, J., Rinaldi, C. A., Ismail, T. F., Chiribiri, A., & Carr‐White, G. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0372-1 · Cited by 50
Wilck, N., Markó, L., Balogh, A., Kräker, K., Herse, F., Bartolomaeus, H., Szijártó, I. A., Gollasch, M., Reichhart, N., Strauß, O., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96006 · Cited by 47
Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat
Lamberts, R. R., Vaessen, R. J., Westerhof, N., & Stienen, G. J. M. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0620-5 · Cited by 47
Werbner, B., Tavakoli‐Rouzbehani, O. M., Fatahian, A. N., & Boudina, S. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.42 · Cited by 44
The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction
Janssen-Telders, C., Eringa, E. C., de Groot, J. R., de Man, F. S., & Handoko, M. L. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf056 · Cited by 57
Rouhana, S., Farah, C., Roy, J., Finan, A., de Araújo, G. R., Bideaux, P., Scheuermann, V., Saliba, Y., Reboul, C., Cazorla, O., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.005 · Cited by 52
Myocardial reverse remodeling: how far can we rewind?
Gonçalves‐Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00696.2015 · Cited by 48
Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction
Paulus, W. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.041 · Cited by 46
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Tona, F., Montisci, R., Iop, L., & Civieri, G. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2021.01.277 · Cited by 48
Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
Henning, R. J. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v12.i1.7 · Cited by 47
Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension
Mazurek, J. A., Horne, B. D., Saeed, W., Sardar, M. R., & Zolty, R. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.12.012 · Cited by 43
Guo, W., Zhu, C., Yin, Z., Wang, Q., Sun, M., Cao, H., & Greaser, M. L. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24117 · Cited by 43
Treating Heart Failure with Preserved Ejection Fraction: Learning from Pulmonary Fibrosis
Graziani, F., Varone, F., Crea, F., & Richeldi, L. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1286 · Cited by 44
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
Herwig, M., Kolijn, D., Lódi, M., Hölper, S., Kov́acs, Á., Papp, Z., Jaquet, K., Haldenwang, P. L., dos Remedios, C. G., Reusch, H. P., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00240 · Cited by 44
Hamdani, N., Borbély, A., Veenstra, S., Kooij, V., Vrydag, W., Zaremba, R., dos Remedios, C. G., Niessen, H. W. M., Michel, M. C., Paulus, W. J., et al. (2010) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9231-8 · Cited by 43
Mou, Y. A., Guennec, J. L., Mosca, E., de Tombe, P. P., & Cazorla, O. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0501-x · Cited by 43
Metadata
- Authors
- Borbély, A., van der Velden, J., Papp, Z., Bronzwaer, J. G. F., Edes, I., Stienen, G. J. M., & Paulus, W. J.
- Affiliations
- From the Laboratory for Physiology (A.B., J.v.d.V., J.G.F.B., G.J.M.S., W.J.P.), Institute for Cardiovascular Research, VUMC, Amsterdam, the Netherlands, and the Division of Clinical Physiology (A.B., Z.P., I.E.), Institute of Cardiology, UDMHSC, Debrecen, Hungary.
- Amsterdam Cardiovascular Sciences (NL)
- Venue
- Circulation
- Published
- 2005-02-15
- Volume
- 111
- Issue
- 6
- Pages
- 774-781
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2140058582
- Cited by
- 536
- References
- 44
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 21 · 2023: 24 · 2022: 25 · 2021: 28 · 2020: 37 · 2019: 20 · 2018: 28 · 2017: 32 · 2016: 35 · 2015: 30 · 2014: 35 · 2013: 24 · 2012: 20
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- heart failure with preserved ejection fraction, cardiomyocyte stiffness, passive tension, collagen volume fraction, sarcomeric proteins, protein kinase A, sarcomere length, diastolic dysfunction, left ventricular end-diastolic pressure, myocardial fibrosis
- MeSH terms
- Aged, Aged, 80 and over, Calcium, Diastole, Female, Heart Failure, Hemodynamics, Humans, Male, Middle Aged, Myocardium, Stroke Volume, Ventricular Function, Left, Ventricular Pressure, Cyclic AMP-Dependent Protein Kinases, Myocytes, Cardiac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
